End-of-day quote
Shenzhen S.E.
23:00:00 25/04/2024 BST
|
5-day change
|
1st Jan Change
|
36.65
CNY
|
-0.49%
|
|
+0.19%
|
+5.99%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
20,370
|
28,280
|
37,427
|
31,529
|
34,221
|
37,244
|
-
|
Enterprise Value (EV)
1 |
18,957
|
28,280
|
37,427
|
31,529
|
34,221
|
37,244
|
37,244
|
P/E ratio
|
27.1
x
|
16.1
x
|
25.4
x
|
19.8
x
|
14.3
x
|
16.7
x
|
14.4
x
|
Yield
|
1.97%
|
1.06%
|
0.79%
|
1.88%
|
2.31%
|
1.7%
|
1.62%
|
Capitalization / Revenue
|
4.39
x
|
4.2
x
|
5.43
x
|
4.44
x
|
4.29
x
|
3.97
x
|
3.47
x
|
EV / Revenue
|
4.39
x
|
4.2
x
|
5.43
x
|
4.44
x
|
4.29
x
|
3.97
x
|
3.47
x
|
EV / EBITDA
|
21.1
x
|
12.7
x
|
19.5
x
|
15.2
x
|
10.9
x
|
15
x
|
13.1
x
|
EV / FCF
|
116,866,821
x
|
13,134,419
x
|
40,819,814
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
0%
|
-
|
-
|
-
|
-
|
Price to Book
|
3.36
x
|
3.8
x
|
4.58
x
|
3.24
x
|
2.95
x
|
2.72
x
|
2.35
x
|
Nbr of stocks (in thousands)
|
1,002,477
|
1,002,477
|
990,127
|
989,625
|
989,625
|
1,002,004
|
-
|
Reference price
2 |
20.32
|
28.21
|
37.80
|
31.86
|
34.58
|
36.65
|
36.65
|
Announcement Date
|
28/02/20
|
28/01/21
|
22/04/22
|
27/04/23
|
26/04/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
4,636
|
6,726
|
6,894
|
7,102
|
7,972
|
9,384
|
10,730
|
EBITDA
1 |
966.9
|
2,224
|
1,917
|
2,079
|
3,131
|
2,481
|
2,840
|
EBIT
1 |
849.9
|
2,010
|
1,688
|
1,842
|
2,893
|
2,536
|
2,943
|
Operating Margin
|
18.33%
|
29.88%
|
24.48%
|
25.93%
|
36.3%
|
27.02%
|
27.42%
|
Earnings before Tax (EBT)
1 |
864.3
|
2,019
|
1,702
|
1,842
|
2,849
|
2,539
|
2,946
|
Net income
1 |
752.6
|
1,759
|
1,482
|
1,595
|
2,396
|
2,197
|
2,548
|
Net margin
|
16.23%
|
26.15%
|
21.5%
|
22.46%
|
30.05%
|
23.42%
|
23.75%
|
EPS
2 |
0.7500
|
1.750
|
1.490
|
1.610
|
2.410
|
2.193
|
2.542
|
Free Cash Flow
|
174.3
|
2,153
|
916.9
|
-
|
-
|
-
|
-
|
FCF margin
|
3.76%
|
32.01%
|
13.3%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
18.03%
|
96.83%
|
47.84%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
23.16%
|
122.4%
|
61.85%
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.4000
|
0.3000
|
0.3000
|
0.6000
|
0.8000
|
0.6233
|
0.5950
|
Announcement Date
|
28/02/20
|
28/01/21
|
22/04/22
|
27/04/23
|
26/04/24
|
-
|
-
|
Fiscal Period: December |
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
-
|
2,277
|
1,683
|
1,309
|
2,231
|
2,282
|
2,060
|
2,616
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
713.5
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
0.7186
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
28/04/23
|
28/08/23
|
24/10/23
|
26/04/24
|
26/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
1,413
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
174
|
2,153
|
917
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
13.1%
|
26.2%
|
19.2%
|
17.5%
|
22.5%
|
16.4%
|
16.3%
|
ROA (Net income/ Total Assets)
|
10%
|
19.5%
|
13.4%
|
11.8%
|
-
|
11.7%
|
11.7%
|
Assets
1 |
7,495
|
9,015
|
11,032
|
13,547
|
-
|
18,846
|
21,781
|
Book Value Per Share
2 |
6.060
|
7.420
|
8.250
|
9.840
|
11.70
|
13.50
|
15.60
|
Cash Flow per Share
2 |
0.6100
|
2.820
|
1.200
|
2.300
|
2.120
|
2.200
|
2.480
|
Capex
1 |
440
|
678
|
284
|
178
|
-
|
431
|
342
|
Capex / Sales
|
9.49%
|
10.08%
|
4.11%
|
2.5%
|
-
|
4.59%
|
3.18%
|
Announcement Date
|
28/02/20
|
28/01/21
|
22/04/22
|
27/04/23
|
26/04/24
|
-
|
-
|
Last Close Price
36.65
CNY Average target price
44.45
CNY Spread / Average Target +21.29% Consensus |
1st Jan change
|
Capi.
|
---|
| +5.99% | 5.07B | | +73.01% | 12.38B | | -18.53% | 7.92B | | +15.79% | 7.2B | | +6.69% | 5.84B | | +27.07% | 4.53B | | -21.67% | 3.88B | | -42.02% | 2.23B | | +0.99% | 2.02B | | +5.07% | 1.88B |
Medical Equipment
|